Keyphrases
Teratogen
100%
Isotretinoin
100%
Thalidomide
100%
Teratogenic
57%
Serum Concentration
28%
Female Patients
28%
Contraception
28%
In Utero Exposure
14%
Patient Education
14%
Teratogenicity
14%
Pharmaceutical Companies
14%
Teratogenic Effects
14%
Women of Reproductive Age
14%
Serum Levels
14%
Drug Therapy
14%
Patient Compliance
14%
Number of Females
14%
Therapeutic Agents
14%
Non-pregnant Women
14%
Lessons Learned
14%
Women's Needs
14%
Therapeutic Potential
14%
Clinical Experience
14%
Pharmacokinetic Variability
14%
Birth Control
14%
Complete Removal
14%
Drug Elimination
14%
Successful Development
14%
Isotretinoin Therapy
14%
Pregnancy Prevention Program
14%
Etretinate
14%
Pharmacology, Toxicology and Pharmaceutical Science
Teratogenic Agent
100%
Isotretinoin
100%
Thalidomide
100%
Elimination
14%
Teratogenicity
14%
Drug
14%
Chemical Teratogen
14%
Pharmacotherapy
14%
Etretinate
14%
Pharmacokinetics
14%